Medical Management of Refractory Status Epilepticus

Seminars in Pediatric Neurology

Volumn 17, Issue 3, 2010, Pages 176-181

  Owens, James ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; PYRIDOXINE; THIOPENTAL; TOPIRAMATE; VALPROIC ACID;

BLOOD BRAIN BARRIER; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERAMMONEMIA; HYPERTRIGLYCERIDEMIA; HYPOTENSION; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER TOXICITY; LOADING DRUG DOSE; MEDICAL ETHICS; METABOLIC ACIDOSIS; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROPOFOL INFUSION SYNDROME; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SEDATION; SIDE EFFECT; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT;

EID: 77955808748     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2010.06.006     Document Type: Review

References (52)

1. Abend N.S., Dlugos D.J. Treatment of refractory status epilepticus: Literature review and a proposed protocol. Pediatr Neurol 2008, 38:377-390.
2. Bleck T.P. Refractory status epilepticus. Curr Opin Crit Care 2005, 11:117-120.
3. Lowenstein D.H. The management of refractory status epilepticus: An update. Epilepsia 2006, 47(suppl 1):35-40.
4. Meierkord H., Boon P., Engelsen B., et al. EFNS guideline on the management of status epilepticus. Eur J Neurol 2006, 13:445-450.
5. Hirsch L.J., Arif H. Status epilepticus. Continuum 2007, 13:121-151.
6. Fujikawa D.G. Prolonged seizures and cellular injury: Understanding the connection. Epilepsy Behav 2005, 7(suppl 3):S3-S11.
7. Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: A prospective observational study. Epilepsia 2010, 51:251-256.
8. Treiman D., Meyers P., Walton H., et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792-798.
9. Claassen J., Hirsch L.J., Emerson R.G., et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002, 43:146-153.
10. Chin R.F., Neville B.G., Peckham C., et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population-based study. Lancet 2006, 368:222-229.
11. Drislane F.W., Blum A.S., Lopez M.R., et al. Duration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours. Epilepsia 2009, 50:1566-1571.
12. Holtkamp M., Othman J., Buchheim K., et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534-539.
13. Claassen J., Lokin J.K., Fitzsimmons B.F., et al. Predictors of functional disability and mortality after status epilepticus. Neurology 2002, 58:139-142.
14. Eriksson K., Metsaranta P., Huhtala H., et al. Treatment delay and the risk of prolonged status epilepticus. Neurology 2005, 65:1316-1318.
15. Reuber M., Elger C.E. Psychogenic non-epileptic seizures: Review and update. Epilepsy Behav 2003, 4:205-216.
16. Binder L.M., Salinsky M.C. Psychogenic non-epileptic seizures. Neuropsychol Rev 2007, 17:405-412.
17. Carreño M. Recognition of non-epileptic events. Semin Neurol 2008, 28:297-304.
18. Benbadis S. The differential diagnosis of epilepsy: A critical review. Epilepsy Behav 2009, 15:15-21.
19. Gospe S.M. Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol 2006, 19:148-153.
20. Bergey G.K. Refractory status epilepticus: is EEG burst suppression an appropriate treatment target during drug-induced coma?. What is the Holy Grail?. Epilepsy Curr 2006, 6:119-120.
21. Krishnamurthy K.B., Drislane F.W. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999, 40:759-762.
22. Rossetti A.O., Logroscino G., Bromfield E.B. Refractory status epilepticus: Effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62:1698-1702.
23. Parviainen I., Kalviainen R., Ruokonen E. Propofol and barbituares for the anesthesia of refractory convulsive status epilepticus: Pros and cons. Neurol Res 2007, 29:667-671.
24. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
25. Kaplan P.W. Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 1999, 30:1-4.
26. Venkatarman V., Wheless J.W. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999, 35:147-153.
27. Trinka E. What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?. Epilepsia 2009, 50(suppl 12):40-43.
28. Mehta V., Singhi P., Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: A randomized controlled trial. J Child Neurol 2007, 22:1191-1197.
29. Riviello J.J., Ashwal S., Hirtz D., et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review). Neurology 2006, 67:1542-1550.
30. Moddel G., Bunten S., Dobis C., et al. Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009, 80:689-692.
31. Gallentine W., Hunnicutt A.S., Husain A.M. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav 2009, 14:215-218.
32. Towne A.R., Garnett L.K., Waterhouse E.J., et al. The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332-334.
33. Niebauer M., Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999, 837:263-269.
34. Shatskikh T., Zhao Q., Zhou J.L., et al. Effect of topiramate on cognitive function and single units following status epilepticus. Epilepsy Behav 2009, 14:40-47.
35. Suchomelova L., Baldwin R.A., Kubova H. Treatment of experimental status epilepticus in immature rats: Dissociation between anticonvulsant and antiepileptogenic effects. Pediatr Res 2006, 59:237-243.
36. Tilz C., Resch R., Hofer T., et al. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2010, 51:316-317.
37. Gilbert D.L., Gartside P.S., Glauser T.A. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta-analysis. J Child Neurol 1999, 14:602-609.
38. Holmes G.L., Riviello J.J. Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999, 20:259-264.
39. Kim S.J., Lee D.Y., Kim J.S. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol 2001, 25:217-220.
40. Neuwelt E.A., Kikuchi K., Hill S.A., et al. Barbiturate inhibition of lymphocyte function. Differing effects of various barbiturates used to induce coma. J Neurosurg 1982, 56:254-259.
41. Stover J.F., Stocker R. Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998, 54:529-534.
42. Naritoku D.K., Sinha S. Prolongation of midazolam half-life after sustained infusion for status epilepticus. Neurology 2000, 54:1366-1368.
43. Brevoord J.C., Joosten K.F., Arts W.F., et al. Status epilepticus: Clinical analysis of a treatment protocol based on midazolam and phenytoin. J Child Neurol 2005, 20:476-481.
44. Koul R., Chacko A., Javed H., et al. Eight-year study of childhood status epilepticus: Midazolam infusion in management and outcome. J Child Neurol 2002, 17:908-910.
45. Morrison G., Gibbons E., Whitehouse W.P. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006, 32:2070-2076.
46. Ozdemir D., Gulez P., Uran N., et al. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure 2005, 14:129-132.
47. Singhi S., Murthy A., Singhi P., et al. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002, 17:106-110.
48. Lowenstein D.H. Treatment options for status epilepticus. Curr Opin Pharmacol 2005, 5:334-339.
49. van Gestel J., Blusse van Oud-Alblas H., Malingre M., et al. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005, 65:591-592.
50. Iyer V., Hoel R., Rabinstein A. Propofol infusion syndrome in patients with refractory status epileptics: An 11-year clinical experience. Crit Care Med 2009, 37:3024-3030.
51. Sethi N.K., Torgvnick J., Arsura E. Refractory status epilepticus in children: When do we stop treatment?. Eur Neurol 2008, 59:94-95.
52. Mayer S.A., Claassen J., Lokin J., et al. Refractory status epilepticus: Frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.